Cocaine-Induced Reinstatement of Cocaine Seeking Provokes Changes in the Endocannabinoid and
Animals
Biomarkers
Brain
/ drug effects
Chromatography, Liquid
Cocaine
/ pharmacology
Cocaine-Related Disorders
/ etiology
Endocannabinoids
/ metabolism
Ethanolamines
/ metabolism
Gene Expression
Immunohistochemistry
Male
Rats
Receptor, Cannabinoid, CB1
/ genetics
Receptor, Cannabinoid, CB2
/ genetics
Receptors, Cannabinoid
Tandem Mass Spectrometry
LC-MS/MS method
N-acylethanolamines
cannabinoid receptors
cocaine reinstatement
endocannabinoids
immunohistochemistry
relapse
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
21 Mar 2019
21 Mar 2019
Historique:
received:
11
02
2019
revised:
14
03
2019
accepted:
19
03
2019
entrez:
24
3
2019
pubmed:
25
3
2019
medline:
16
7
2019
Statut:
epublish
Résumé
There is strong support for the role of the endocannabinoid system and the noncannabinoid lipid signaling molecules,
Identifiants
pubmed: 30901889
pii: molecules24061125
doi: 10.3390/molecules24061125
pmc: PMC6470884
pii:
doi:
Substances chimiques
Biomarkers
0
Endocannabinoids
0
Ethanolamines
0
N-acylethanolamines
0
Receptor, Cannabinoid, CB1
0
Receptor, Cannabinoid, CB2
0
Receptors, Cannabinoid
0
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Science and Higher Education, Warszawa, Poland
ID : N N404 273040
Références
Nat Med. 2001 Oct;7(10):1151-4
pubmed: 11590440
FEBS Lett. 2001 Oct 12;506(3):253-6
pubmed: 11602256
Pharmacol Rep. 2005 Jan-Feb;57(1):35-46
pubmed: 15849375
J Neurosci. 2006 Aug 16;26(33):8531-6
pubmed: 16914679
Pharmacol Rep. 2006 Nov-Dec;58(6):806-19
pubmed: 17220538
J Neurosci. 2007 Jan 24;27(4):791-5
pubmed: 17251418
Eur J Pharmacol. 2008 Dec 3;599(1-3):58-64
pubmed: 18848829
J Neurosci. 2008 Dec 17;28(51):13985-94
pubmed: 19091987
Trends Neurosci. 2009 Oct;32(10):517-24
pubmed: 19758714
J Physiol Pharmacol. 2009 Sep;60(3):119-25
pubmed: 19826190
Eur J Pharmacol. 2010 Feb 10;627(1-3):142-9
pubmed: 19878670
Neuroscience. 2010 Feb 17;165(4):1377-89
pubmed: 19961906
Addict Biol. 2010 Jul;15(3):277-88
pubmed: 20477753
Science. 2011 Jul 15;333(6040):353-7
pubmed: 21764750
Neuroscience. 2012 Mar 1;204:117-24
pubmed: 21871539
Neurochem Int. 2012 Jan;60(2):145-52
pubmed: 22133429
Neuroscience. 2012 Mar 1;204:74-82
pubmed: 22192839
Neuron. 2012 Jan 26;73(2):360-73
pubmed: 22284189
Brain Res. 2012 Mar 20;1444:45-54
pubmed: 22325096
Addict Biol. 2013 Jan;18(1):78-87
pubmed: 23163925
J Histochem Cytochem. 2013 Jul;61(7):529-47
pubmed: 23657829
Neuropharmacology. 2014 Jan;76 Pt B:370-82
pubmed: 23747571
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:1-10
pubmed: 24334211
Toxicol Mech Methods. 2014 May;24(4):315-22
pubmed: 24576199
Front Psychiatry. 2014 Jul 31;5:92
pubmed: 25132823
Neurotox Res. 2015 Apr;27(3):246-58
pubmed: 25408547
Curr Neuropharmacol. 2014 Sep;12(5):462-74
pubmed: 25426013
Toxicol Appl Pharmacol. 2015 Aug 1;286(3):178-87
pubmed: 25933444
Cell Rep. 2015 Sep 29;12(12):1997-2008
pubmed: 26365195
Neuropharmacology. 2017 Sep 15;124:25-37
pubmed: 28392266
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jul 13;85:180-188
pubmed: 28392485
Pharmacol Biochem Behav. 2018 Mar;166:1-12
pubmed: 29337083
Neurotox Res. 2018 Oct;34(3):547-558
pubmed: 29754307
Eur J Pharmacol. 2018 Sep 5;834:230-239
pubmed: 30036537